A Phase III Study of GS101 Injection to Dupixent®

Clinical trial NCT07386743 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07386743
Sponsor: Jiangsu Genscend Biopharmaceutical Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Atopic Dermatitis (AD)

Start date: 2026-02-01
Primary completion: 2027-04-01
Enrollment: 572

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.